Maud Mavigner

2.3k total citations
35 papers, 1.1k citations indexed

About

Maud Mavigner is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Maud Mavigner has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Virology, 20 papers in Infectious Diseases and 14 papers in Immunology. Recurrent topics in Maud Mavigner's work include HIV Research and Treatment (30 papers), Immune Cell Function and Interaction (12 papers) and HIV/AIDS Research and Interventions (11 papers). Maud Mavigner is often cited by papers focused on HIV Research and Treatment (30 papers), Immune Cell Function and Interaction (12 papers) and HIV/AIDS Research and Interventions (11 papers). Maud Mavigner collaborates with scholars based in United States, France and Australia. Maud Mavigner's co-authors include Michelle Cazabat, Jacques Izopet, Pierre Delobel, Patrice Massip, B. Marchou, Ann Chahroudi, Stéphanie Raymond, Guido Silvestri, Corinne Souyris and Karine Sauné and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Maud Mavigner

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maud Mavigner United States 19 878 576 456 304 126 35 1.1k
Levelle D. Harris United States 8 560 0.6× 292 0.5× 452 1.0× 243 0.8× 115 0.9× 9 838
Fedde Groot Netherlands 13 621 0.7× 278 0.5× 434 1.0× 157 0.5× 215 1.7× 14 920
Jennifer Stanton United States 10 648 0.7× 505 0.9× 199 0.4× 125 0.4× 107 0.8× 10 806
Kevin T. Stephan United States 10 658 0.7× 451 0.8× 409 0.9× 175 0.6× 109 0.9× 14 1.0k
Mariane Høgsbjerg Schleimann Denmark 11 544 0.6× 491 0.9× 262 0.6× 160 0.5× 184 1.5× 23 850
Miranda Z. Smith Australia 16 561 0.6× 270 0.5× 429 0.9× 187 0.6× 93 0.7× 28 809
Mariantonietta Di Stefano Italy 16 487 0.6× 411 0.7× 148 0.3× 238 0.8× 57 0.5× 46 806
Vicky Coalter United States 10 575 0.7× 238 0.4× 360 0.8× 203 0.7× 83 0.7× 10 684
Julie Czartoski United States 11 512 0.6× 356 0.6× 406 0.9× 150 0.5× 163 1.3× 15 890
María Abad-Fernández Spain 12 393 0.4× 272 0.5× 197 0.4× 159 0.5× 35 0.3× 31 569

Countries citing papers authored by Maud Mavigner

Since Specialization
Citations

This map shows the geographic impact of Maud Mavigner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maud Mavigner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maud Mavigner more than expected).

Fields of papers citing papers by Maud Mavigner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maud Mavigner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maud Mavigner. The network helps show where Maud Mavigner may publish in the future.

Co-authorship network of co-authors of Maud Mavigner

This figure shows the co-authorship network connecting the top 25 collaborators of Maud Mavigner. A scholar is included among the top collaborators of Maud Mavigner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maud Mavigner. Maud Mavigner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Shuang, Sean C. Patro, Brian T. Luke, et al.. (2025). Divergent populations of HIV-infected naive and memory CD4+ T cell clones in children on antiretroviral therapy. Journal of Clinical Investigation. 135(9). 1 indexed citations
2.
Zimmerman, Matthew G., Mehul S. Suthar, Nils Schoof, et al.. (2023). Treatment with sofosbuvir attenuates the adverse neurodevelopmental consequences of Zika virus infection in infant rhesus macaques. Journal of Neuroimmunology. 381. 578148–578148. 7 indexed citations
3.
Damhorst, Gregory L., Nils Schoof, Hans Verkerke, et al.. (2023). Investigation of Blood Plasma Viral Nucleocapsid Antigen as a Marker of Active Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection. Open Forum Infectious Diseases. 10(5). ofad226–ofad226. 1 indexed citations
4.
5.
Lippy, Adriana, Brian G. Oliver, James T. Fuller, et al.. (2021). Rapid progression is associated with lymphoid follicle dysfunction in SIV-infected infant rhesus macaques. PLoS Pathogens. 17(5). e1009575–e1009575. 5 indexed citations
6.
Babiker, Ahmed, Samuel D. Stampfer, Anuradha Rao, et al.. (2021). Single-Amplicon Multiplex Real-Time Reverse Transcription-PCR with Tiled Probes To Detect SARS-CoV-2 spike Mutations Associated with Variants of Concern. Journal of Clinical Microbiology. 59(12). e0144621–e0144621. 18 indexed citations
7.
Singh, Vidisha, Amir Dashti, Maud Mavigner, & Ann Chahroudi. (2021). Latency Reversal 2.0: Giving the Immune System a Seat at the Table. Current HIV/AIDS Reports. 18(2). 117–127. 26 indexed citations
8.
Chahroudi, Ann, et al.. (2021). New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models. Viruses. 13(8). 1560–1560. 11 indexed citations
9.
Raper, Jessica, Zsofia Kovacs‐Balint, Maud Mavigner, et al.. (2020). Long-term alterations in brain and behavior after postnatal Zika virus infection in infant macaques. Nature Communications. 11(1). 2534–2534. 44 indexed citations
10.
Dashti, Amir, Maud Mavigner, Nils Schoof, et al.. (2020). SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques. Journal of Virology. 94(21). 26 indexed citations
14.
Mavigner, Maud, Claire Deléage, Elias P. Rosen, et al.. (2018). Simian Immunodeficiency Virus Persistence in Cellular and Anatomic Reservoirs in Antiretroviral Therapy-Suppressed Infant Rhesus Macaques. Journal of Virology. 92(18). 48 indexed citations
16.
Green, Richard, Rachel Brown, Tiffany Hensley‐McBain, et al.. (2018). Liver macrophage-associated inflammation correlates with SIV burden and is substantially reduced following cART. PLoS Pathogens. 14(2). e1006871–e1006871. 22 indexed citations
17.
Chahroudi, Ann, Emily K. Cartwright, Maud Mavigner, et al.. (2014). Target Cell Availability, Rather than Breast Milk Factors, Dictates Mother-to-Infant Transmission of SIV in Sooty Mangabeys and Rhesus Macaques. PLoS Pathogens. 10(3). e1003958–e1003958. 33 indexed citations
18.
Mavigner, Maud, Benjamin Watkins, Benton Lawson, et al.. (2014). Persistence of Virus Reservoirs in ART-Treated SHIV-Infected Rhesus Macaques after Autologous Hematopoietic Stem Cell Transplant. PLoS Pathogens. 10(9). e1004406–e1004406. 50 indexed citations
19.
Raymond, Stéphanie, Pierre Delobel, Maud Mavigner, et al.. (2009). Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage. Journal of Clinical Virology. 47(2). 126–130. 53 indexed citations
20.
Raymond, Stéphanie, Pierre Delobel, Maud Mavigner, et al.. (2008). Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism. AIDS. 22(14). F11–F16. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026